These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27450181)

  • 1. Screening of Natural Products and Derivatives for the Identification of RND Efflux Pump Inhibitors.
    Choudhury D; Talukdar AD; Chetia P; Bhattacharjee A; Choudhury MD
    Comb Chem High Throughput Screen; 2016; 19(9):705-713. PubMed ID: 27450181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of piperine on the inhibitory potential of MexAB-OprM efflux pump and imipenem resistance in carbapenem-resistant Pseudomonas aeruginosa.
    Liu Y; Zhu R; Liu X; Li D; Guo M; Fei B; Ren Y; You X; Li Y
    Microb Pathog; 2023 Dec; 185():106397. PubMed ID: 37852553
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Abdelmalek S; Hajar M; Salah L; Abdel-Halim H
    Microb Drug Resist; 2024 Feb; 30(2):73-81. PubMed ID: 38150012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of avoidance and inhibition of
    Gervasoni S; Mehla J; Bergen CR; Leus IV; Margiotta E; Malloci G; Bosin A; Vargiu AV; Lomovskaya O; Rybenkov VV; Ruggerone P; Zgurskaya HI
    mBio; 2023 Aug; 14(4):e0140323. PubMed ID: 37493633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efflux pump inhibitors of MexAB- or MexXY-OprM in Pseudomonas aeruginosa using nucleic acid dyes.
    Fujiwara M; Yamasaki S; Morita Y; Nishino K
    J Infect Chemother; 2022 May; 28(5):595-601. PubMed ID: 35168878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in
    Tambat R; Mahey N; Chandal N; Verma DK; Jangra M; Thakur KG; Nandanwar H
    ACS Infect Dis; 2022 Feb; 8(2):255-270. PubMed ID: 35045260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa.
    Mehla J; Malloci G; Mansbach R; López CA; Tsivkovski R; Haynes K; Leus IV; Grindstaff SB; Cascella RH; D'Cunha N; Herndon L; Hengartner NW; Margiotta E; Atzori A; Vargiu AV; Manrique PD; Walker JK; Lomovskaya O; Ruggerone P; Gnanakaran S; Rybenkov VV; Zgurskaya HI
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India.
    Choudhury D; Ghose A; Dhar Chanda D; Das Talukdar A; Dutta Choudhury M; Paul D; Maurya AP; Chakravarty A; Bhattacharjee A
    PLoS One; 2016; 11(2):e0149156. PubMed ID: 26866484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.